About Krsnaa Diagnostics
Krsnaa Diagnostics is a company based in Pune (India) founded in 2011 by Yogesh Arbat. Krsnaa Diagnostics has raised $23.61 million across 4 funding rounds from investors including Somerset Indus Capital Partners, Phi Capital and Kitara Capital. The company has 5,910 employees as of March 31, 2024. Krsnaa Diagnostics operates in a competitive market with competitors including Thyrocare, Suraksha Diagnostics, Vijaya Diagnostic Centre, Aarthi Scans and Igenetic, among others.
- Headquarter Pune, India
- Employees 5910 as on 31 Mar, 2024
- Founders Yogesh Arbat
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Krsnaa Diagnostics Limited
-
Annual Revenue
$83.92 M (USD)15.74as on Mar 31, 2025
-
Net Profit
$9.08 M (USD)36.54as on Mar 31, 2025
-
EBITDA
$22.47 M (USD)31.6as on Mar 31, 2025
-
Total Equity Funding
$23.61 M (USD)
in 4 rounds
-
Latest Funding Round
$2.89 M (USD), Series B
Mar 29, 2019
-
Investors
Somerset Indus Capital Partners
& 13 more
-
Employee Count
5910
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Krsnaa Diagnostics
Krsnaa Diagnostics is a publicly listed company on the NSE with ticker symbol KRSNAA in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Krsnaa Diagnostics
Unlock access to complete
Funding Insights of Krsnaa Diagnostics
Krsnaa Diagnostics has successfully raised a total of $23.61M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2.89 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Krsnaa Diagnostics
Krsnaa Diagnostics has secured backing from 14 investors, including venture fund and angel investors. Prominent investors backing the company include Somerset Indus Capital Partners, Phi Capital and Kitara Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Investment management and co-investment services through global networks.
|
Locked | Locked | Locked | |
|
Healthcare investments focused on accessibility, affordability, and ESG integration in India.
|
Locked | Locked | Locked |
Investor details for Krsnaa Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Krsnaa Diagnostics
Investment portfolio details for Krsnaa Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Krsnaa Diagnostics
Detailed financials for Krsnaa Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Krsnaa Diagnostics Comparisons
Peer comparison for Krsnaa Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Krsnaa Diagnostics
Krsnaa Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Thyrocare, Suraksha Diagnostics, Vijaya Diagnostic Centre, Aarthi Scans and Igenetic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic testing centers for pathology and health screenings are operated.
|
|
| Locked | Locked | Locked |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| Locked | Locked | Locked |
Diagnostic services are offered via a chain of centers.
|
|
| Locked | Locked | Locked |
Chain of diagnostic centers
|
|
| Locked | Locked | Locked |
Provider molecular diagnostic solutions and services
|
Detailed competitors of Krsnaa Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Krsnaa Diagnostics
Complete news archive for Krsnaa Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krsnaa Diagnostics
Krsnaa Diagnostics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Krsnaa Diagnostics is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Mitesh Dave is the current CEO of Krsnaa Diagnostics.
Krsnaa Diagnostics is a funded company, having raised a total of $23.61M across 4 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Krsnaa Diagnostics is 5,910.
Annual revenue of Krsnaa Diagnostics is $83.92M as on Mar 31, 2025.
Chain of radiology pathology laboratory centers. Its diagnostic imaging includes MRI, CT, X-ray, ultrasound, remote radiology reporting, and consultation. It also offers home sample collection and telepathology.
Krsnaa Diagnostics's top competitors include Thyrocare, Suraksha Diagnostics and Vijaya Diagnostic Centre.
Yes, Krsnaa Diagnostics is publicly traded on NSE under the ticker symbol KRSNAA.
Krsnaa Diagnostics has 14 investors. Key investors include Somerset Indus Capital Partners, Phi Capital, Kitara Capital, Kiran Kumar Bhise, and Rajendra Mutha.
The ticker symbol of Krsnaa Diagnostics is KRSNAA on NSE.
The valuation of Krsnaa Diagnostics is $61.18M as of Mar 2019.